Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John H. Kearsley
Anti-Muc1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in Vivo Ovarian Cancer Model
PLoS ONE
Multidisciplinary
Related publications
Bismuth-213 Radioimmunotherapy With C595 Anti–MUC1 Monoclonal Antibody in an Ovarian Cancer Ascites Model
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Anti-Il-20 Monoclonal Antibody Alleviates Inflammation in Oral Cancer and Suppresses Tumor Growth
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Development of a Chimeric Anti-Cd40 Monoclonal Antibody That Synergizes With LEA29Y to Prolong Islet Allograft Survival
Journal of Immunology
Allergy
Immunology
Anti-Kl-6/Muc1 Monoclonal Antibody Reverses Resistance to Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity by Capping MUC1
Cancer Letters
Cancer Research
Oncology
Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice
International Journal of Cancer
Cancer Research
Oncology
An Anti-Cd133 Monoclonal Antibody CMab-43 Exerts Anti-Tumor and Anti-Metastasis Activities for Colon Cancers
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Ovarian Tumor-Stroma Interactions in an in Vivo Orthotopic Model
Hormone-Receptor Expression and Ovarian Cancer Survival: An Ovarian Tumor Tissue Analysis Consortium Study
The Lancet Oncology
Oncology
A Novel Anti-Histone H1 Monoclonal Antibody, SSV Monoclonal Antibody, Improves Lung Injury and Survival in a Mouse Model of Lipopolysaccharide-Induced Sepsis-Like Syndrome
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
